about
Assessment of collagen-induced arthritis using cyanine 5.5 conjugated with hydrophobically modified glycol chitosan nanoparticles: correlation with 18F-fluorodeoxyglucose positron emission tomography data.Factors of importance for a successful delivery system for proteins.Neonatal Immune Tolerance Induction to Allow Long-Term Studies With an Immunogenic Therapeutic Monoclonal Antibody in MiceToxicity as a result of immunostimulation by biologics.Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving ChemotherapyClinical concerns of immunogenicity produced at cellular levels by biopharmaceuticals following their parenteral administration into human body.Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris.Post-production protein stability: trouble beyond the cell factory.Safety Evaluation of Lipid Nanoparticle-Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey.Microparticles and Nanoparticles Delivered in Intravenous Saline and in an Intravenous Solution of a Therapeutic Antibody Product.Optical Detection of Degraded Therapeutic Proteins.A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals
P2860
Q34331895-47CA373D-CAEF-4B69-8B31-98C2D78AFC46Q36316926-2ADF1E0B-C9F8-40AA-8308-C45D67C5A1CFQ36653919-60951D2E-CE46-4726-9947-97F29238E313Q36788414-3D58EB8D-5A3C-4052-8D9B-AFF65FDC12F6Q37072872-D850420C-4076-46B0-A477-4706DF34A491Q37700537-5B376E7C-CBB9-42B4-AE16-98D0096CCF70Q37952121-17EC4726-D5BB-4287-929F-3F9C65C62C2FQ38264351-88B1E4BE-2769-480B-BD4F-3A29E8742589Q46250879-2C224E1D-1D87-4CC3-8966-4560E548A2A5Q48036411-A6C41CED-6446-4783-97AA-B8998CFDEC7DQ55080464-0937EA1C-A1B8-4723-B16C-3768232307D1Q58895670-E0B6A0E9-3514-4042-973B-800DA140F596
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antibody-mediated side effects of recombinant proteins.
@ast
Antibody-mediated side effects of recombinant proteins.
@en
type
label
Antibody-mediated side effects of recombinant proteins.
@ast
Antibody-mediated side effects of recombinant proteins.
@en
prefLabel
Antibody-mediated side effects of recombinant proteins.
@ast
Antibody-mediated side effects of recombinant proteins.
@en
P1433
P1476
Antibody-mediated side effects of recombinant proteins.
@en
P2093
Heiner Frost
P304
P356
10.1016/J.TOX.2004.12.028
P407
P577
2005-04-01T00:00:00Z